European Research: Still Fragmented After All These Years (AlphaGalileo, 8 February 2013)
European Medicines Agency starts safety review of Diane 35 and its generics (EMA press release, 8 February 2013)

Novo Nordisk hit hard by U.S. blow to insulin drug (Reuters, 11 February 2013)

11 Feb 2013

Novo Nordisk has responded to reports that the U.S. Food and Drug Administration has requested additional data from a trial of cardiovascular effects before it can approve long-acting insulin Tresiba and related product Ryzodeg.

Full article

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read